You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 112 No. 11, November 1986 TABLE OF CONTENTS
  Archives
  •  Online Features
  PAPERS READ BEFORE THE AMERICAN SOCIETY FOR HEAD AND NECK SURGERY
 This Article
 •References
 •Full text PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Juvenile Angiofibromas

Behavior and Treatment of Extensive and Residual Tumors

Gregory C. Jones, MD; Lawrence W. DeSanto, MD; J. William Bremer, MD; H. Bryan Neel, III, MD, PhD

Arch Otolaryngol Head Neck Surg. 1986;112(11):1191-1193.


Abstract

• In a 15-year period, 40 juvenile angiofibromas were treated surgically (lateral or extended rhinotomy) at the Mayo Clinic, Rochester, Minn. Tumors were staged according to size and extension by using the Sessions classification. Stage III tumors involved the middle fossa or cavernous sinus or both structures, with or without extension into the orbit. Seven patients had stage I, ten had stage IIA, and six had stage IIB disease. Five tumors extended to the skull base (stage IIC). There were 12 cases that included intracranial extension (stage III), none of which involved the sella. There were eight cases with residual tumor: four (stages IIB [one], IIC [one], and III [two]) were not treated again, and four (stage III) were treated with various methods, including operation, embolization, and irradiation. No patient died. No complications or morbidity was experienced by the four patients who were not treated for residual tumor.

(Arch Otolaryngol Head Neck Surg 1986;112:1191-1193)



Author Affiliations

From the Department of Otorhinolaryngology, Mayo Clinic and Mayo Foundation, Rochester, Minn.


Footnotes

Accepted for publication July 13, 1986.

Read before the American Society for Head and Neck Surgery, Palm Beach, Fla, May 8, 1986.

Reprint requests to Department of Otorhinolaryngology, Mayo Clinic, 200 First St SW, Rochester, MN 55905 (Dr DeSanto).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Angiofibroma: Changes in Staging and Treatment
Radkowski et al.
Arch Otolaryngol Head Neck Surg 1996;122:122-129.
ABSTRACT  

Surgical Management of Nasopharyngeal Angiofibroma Involving the Cavernous Sinus
Close et al.
Arch Otolaryngol Head Neck Surg 1989;115:1091-1095.
ABSTRACT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1986 American Medical Association. All Rights Reserved.